To mark Daffodil Day, we chat to two cancer survivors to learn what living with cancer is like - they say it's important to stay positive during treatment and to reach out to friends and family ...

Backed by more than a dozen investors, the biotech startup will use the funding to further a Phase 1 trial of its lead program CBX-250.

Crossbow Therapeutics, Inc., a biotechnology company developing a novel class of potent and precise antibody therapies to treat ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...

To mark Daffodil Day, we chat to a cancer survivor to learn what living with cancer is like – Emma Butler was diagnosed with a rare form of cancer that usually affects older men ...

Size-exclusion chromatography (SEC) was used to purify extracellular vesicles (EVs) from the plasma of chronic myeloid leukemia (CML) patients to evaluate treatment responses and mutation statuses.

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has announced the publication 1 in the Journal of Clinical Pathology of a study conducted in collaboration with the Memorial ...

Chronic rhinosinusitis may be linked to an increased risk for cancer, according to a study of patients in Asia. The study found that chronic rhinosinusitis was linked to an 18% increased risk for ...

More options with new innovative therapy are now available for patients who do not respond well to current first- and second-line therapies.[i] Petaling Jaya, 23 February 2026 – Novartis Malaysia has ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Data Trends provide quick, visually memorable data-driven information and insights that are useful in clinical practice. Here, we explore recent treatment updates in chronic lymphocytic leukemia (CLL) ...

A new lab study published in the journal Global Medical Genetics reports that cannabidiol (CBD) could help counter resistance to a key leukemia drug by reshaping tiny genetic regulators carried in ...